Clinical Trials Logo

Gastric Ulcer clinical trials

View clinical trials related to Gastric Ulcer.

Filter by:

NCT ID: NCT01452711 Completed - Gastric Ulcer Clinical Trials

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer

Start date: November 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the efficacy of TAK-438, once daily (QD), compared to lansoprazole in patients with gastric ulcer.

NCT ID: NCT01435525 Completed - Clinical trials for Early Gastric Cancer

Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation

Start date: September 2011
Phase: N/A
Study type: Observational

The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy in patients given triple therapy for Helicobacter pylori eradication with Nexium + amoxicillin (AMPC) + clarithromycin (CAM), or Nexium + AMPC + metronidazole (MNZ) in usual post-marketing use.

NCT ID: NCT01190657 Completed - Gastric Ulcer Clinical Trials

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

Start date: May 2010
Phase: Phase 4
Study type: Interventional

This is a self-controlled, open, multiple-center clinical trial.

NCT ID: NCT01150162 Completed - Gastric Ulcer Clinical Trials

Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation

MGES
Start date: October 2010
Phase: Phase 3
Study type: Interventional

A Prospective Randomized, Multi-center study to assess the Safety and Efficacy of Mucosta (Rebamipide), in combination with Omeprazole as adjuvant therapy in Gastric Ulcer Patients.

NCT ID: NCT01129011 Completed - Gastric Ulcer Clinical Trials

Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

Start date: September 2007
Phase: Phase 3
Study type: Interventional

This study uses a randomized, double-blind, controlled design to demonstrate that PN400 (esomeprazole and naproxen) is more effective in reducing the occurrence of gastroduodenal ulcers, dyspepsia, and heartburn in subjects at risk for developing NSAID-associated gastric ulcers compared to naproxen alone.

NCT ID: NCT00961350 Completed - Gastric Ulcer Clinical Trials

A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

Start date: October 2009
Phase: Phase 3
Study type: Interventional

Primary: To demonstrate that PA32540 causes fewer gastric ulcers in subjects at risk for developing aspirin-associated gastric ulcers compared to enteric coated (EC) aspirin 325 mg.

NCT ID: NCT00960869 Completed - Gastric Ulcer Clinical Trials

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

Start date: October 2009
Phase: Phase 3
Study type: Interventional

Primary: To demonstrate that PA32540 causes fewer gastric ulcers in subjects at risk for developing aspirin-associated gastric ulcers compared to enteric coated (EC) aspirin 325 mg.

NCT ID: NCT00595517 Completed - Clinical trials for Rheumatoid Arthritis

Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the Safety and tolerability of D961H (Esomeprazole) 20 mg once daily for up to 52 weeks of treatment involving patients with a history of gastric and/or duodenal ulcers receiving daily nonsteroidal anti-inflammatory drug (NSAID) therapy by evaluating AE, clinical laboratory value and vital signs.

NCT ID: NCT00542789 Completed - Clinical trials for Rheumatoid Arthritis

Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

Start date: August 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of esomeprazole (D961H) 20 mg versus placebo once daily for up to 24 weeks of treatment involving patients with a history of gastric and/or duodenal ulcers receiving daily nonsteroidal anti-inflammatory drug (NSAID) therapy by evaluating presence or absence of gastric and/or duodenal ulcers throughout the treatment period (24 weeks) in terms of efficacy on prevention of gastric and/or duodenal ulcers

NCT ID: NCT00527904 Completed - Gastric Ulcer Clinical Trials

A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

Start date: March 2007
Phase: Phase 3
Study type: Interventional

This study uses an open-label design and will be conducted in approximately 60 sites aiming to enroll a total number of 200 subjects to ensure that at least 100 subjects will have 12 months exposure to PN400 (VIMOVO).